Kymera Therapeutics
KYMR
KYMR
125 hedge funds and large institutions have $1.93B invested in Kymera Therapeutics in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
30% less capital invested
Capital invested by funds: $2.76B → $1.93B (-$825M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
125
Holding in Top 10
4
Calls
$10.6M
Puts
$2.56M
Top Buyers
| 1 | +$27.3M | |
| 2 | +$25.2M | |
| 3 | +$22.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$19.2M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$17.2M |
Top Sellers
| 1 | -$42.5M | |
| 2 | -$18.6M | |
| 3 | -$17.9M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$12.7M |
| 5 |
Jennison Associates
New York
|
-$11.6M |